SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 69 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $17,000 | -5.6% | 1,900 | -5.0% | 0.00% | 0.0% |
| Q1 2019 | $18,000 | -25.0% | 2,000 | -78.5% | 0.00% | 0.0% |
| Q4 2018 | $24,000 | +1100.0% | 9,300 | +4550.0% | 0.00% | – |
| Q3 2018 | $2,000 | -71.4% | 200 | -95.5% | 0.00% | – |
| Q2 2018 | $7,000 | -41.7% | 4,400 | -57.7% | 0.00% | -100.0% |
| Q1 2018 | $12,000 | -88.7% | 10,400 | -54.8% | 0.00% | -75.0% |
| Q4 2017 | $106,000 | – | 23,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |